Envoy Medical (COCH) Return on Capital Employed (2021 - 2026)

Envoy Medical has disclosed Return on Capital Employed across 6 years of filings, most recently posting 331.31% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 331.31%, up 24733.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 331.31% (up 24733.0% YoY), and the FY2025 annual result was 1470.94%, up 228463.0% from the prior year.
• Return on Capital Employed came in at 331.31% for Q1 2026 at Envoy Medical, down from 697.57% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 4414.68% in Q2 2024 to a low of 38921.9% in Q3 2025.
• The 5-year median for Return on Capital Employed is 63.6% (2023), against an average of 2117.88%.
• Across the five-year window, Return on Capital Employed jumped 445053 bps in 2024 and sank 4105011 bps in 2025, its largest moves.
• Envoy Medical's Return on Capital Employed stood at 3.34% in 2022, then slumped by 7281 bps to 246.17% in 2023, then tumbled by 167 bps to 657.35% in 2024, then soared by 206 bps to 697.57% in 2025, then sank by 147 bps to 331.31% in 2026.
• The last three Return on Capital Employed figures came in at 331.31% (Q1 2026), 697.57% (Q4 2025), and 38921.9% (Q3 2025), per Business Quant data.